Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2007
12/05/2007EP1768973B1 Substituted quinolones
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1353681B1 Bifidobacteria capable of preventing diarrhea
12/05/2007EP1223976B1 Novel process for making human papillomavirus virus-like particles with improved properties
12/05/2007CN101084232A Antiviral oligonucleotides
12/05/2007CN101084042A Novel vaccine for veterinary and human medicine prophylaxis and therapy
12/05/2007CN101082042A Application of artificial reconstructed defect type human 3-type adenovirus
12/05/2007CN101081866A Domestic animal and aquatic product causal agent resistant specific IgY or compound IgY and application thereof
12/05/2007CN101081864A A plurality of reconstructing antibiotic peptide and preparation method and application thereof
12/05/2007CN101081863A Lipopolysaccharide conjugated protein and monoclonal antibody and preparation method and usage
12/05/2007CN101081860A Polyene antibiotic diester compound
12/05/2007CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
12/05/2007CN101081315A Medical devices containing rapamycin analogs and method for forming same
12/05/2007CN101081298A Method for preparation of novel subunit vaccine for treating porcine pseudorabies
12/05/2007CN101081297A Fowl multi-killed pasteurellosis bacillus live vaccine
12/05/2007CN101081296A Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof
12/05/2007CN101081295A Antibiotic, composition containg antibiotic and method for the administration of antibiotic and said composition to livestock
12/05/2007CN101081294A Chinese traditional medicine spray for preventing and treating upper respiratory tract infection
12/05/2007CN101081287A Health products Chinese medicinal materials health products for relieving hepatitis
12/05/2007CN101081262A Chinese medicinal material preparation for treating orchitis and method for preparing the same
12/05/2007CN101081257A Chinese medicinal material preparations for treating dysentery
12/05/2007CN101081255A kazukiyo oral liquid agent and its preparing process
12/05/2007CN101081253A Chinese medicinal materials preparations for treating rheum
12/05/2007CN101081248A Medicine for treating tetanus and the preparing method and the medicine taking method
12/05/2007CN101081238A Gene therapy for preventing and curing highly pathogenic bird flu and enteron disease
12/05/2007CN101081227A Composition of diammonium glycyrrhizinate
12/05/2007CN101081216A Carbostyrile genus antibiotic preparation took orally
12/05/2007CN101081211A Water indissoluble carbostyrile compound injection and method for preparing the same
12/05/2007CN101081210A Carbostyrile antibiotic injection preparations
12/05/2007CN101081090A Plantain beverage for protecting liver
12/05/2007CN101081075A Selenium germanium peptide jujube tea paste for effecting radical cure of tuberculosis, slow and fume
12/05/2007CN101081073A Selenium germanium peptide jujube tea paste for effecting radical cure of hepatitis B
12/05/2007CN101081049A Green grape health tea
12/05/2007CN100352924C BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
12/05/2007CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007CN100352921C Compositions and methods for identifying antigens which elicit an immune response
12/05/2007CN100352841C Antibiotic peptide and its coding sequence and uses
12/05/2007CN100352837C Pegylated T1249 polypeptide
12/05/2007CN100352836C Novel depsipeptides and process for preparing same
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352807C Chemical compounds
12/05/2007CN100352513C Novel mucous membrane vaccine for newcastle disease and its construction method
12/05/2007CN100352509C Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
12/05/2007CN100352500C Stable liquid formulations of antibodies
12/05/2007CN100352495C Stabilized pharmaceutical composition in lyophilized form
12/05/2007CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor
12/05/2007CN100352493C Method of treating tumors
12/05/2007CN100352490C Traditional Chinese Medicine for treating AIDS and preparation method
12/05/2007CN100352468C Yinzhihuang tablet of oriental wormwood, cape jasmine and baicalin, and its preparing and detecting method
12/05/2007CN100352451C Composition for preventing and treating aftosa
12/05/2007CN100352429C Chinese medicine soft capsule for treating hepatitis B and its preparation method
12/05/2007CN100352427C Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
12/04/2007US7304186 Synthetic method and novel chemical compounds
12/04/2007US7304089 Preparation for improved dietary utilisation
12/04/2007US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/04/2007US7304085 Nitrogen-containing heteroaryl derivatives
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304075 Aqueous solution of sitafloxacin and sodium chloride; photostable microorganisms
12/04/2007US7304068 Viricide against herpes virus; 3-(2-Fluoropyridin-4-yl)-2-phenyl-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidine; chemical synthesis
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007US7304050 Antibacterial agents
12/04/2007US7304043 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
12/04/2007US7303890 Proteins, genes encoding them and method of using the same
12/04/2007US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof
12/04/2007US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007US7303868 Mutant bank
12/04/2007US7303755 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine
12/04/2007US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
12/04/2007US7302913 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
12/04/2007CA2445744C Antiviral nucleoside derivatives
12/04/2007CA2427856C The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
12/04/2007CA2265815C Formulations for topical use
12/04/2007CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007CA2224724C Subunit vaccine against flavivirus infection
12/04/2007CA2212205C Use of xanthine derivatives for the modulation of apoptosis
12/04/2007CA2121241C Porcine reproductive respiratory syndrome vaccine and diagnostic
11/2007
11/30/2007CA2591352A1 Treatment for herpes simplex virus and other infectious diseases
11/29/2007WO2007137279A2 Herv-k antigens, antibodies, and methods
11/29/2007WO2007136982A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/29/2007WO2007136737A1 Methods and compositions for the treatment of viral infections
11/29/2007WO2007136719A2 Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
11/29/2007WO2007136302A2 Active substances, pharmaceutical composition and a method for the production and use thereof
11/29/2007WO2007136300A2 Substituted indoles and a method for the production and use thereof
11/29/2007WO2007135398A1 Indole derivatives
11/29/2007WO2007135163A1 Use of poly(hexamethylene biguanide)hydrochloride as an antiviral agent
11/29/2007WO2007135134A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiaz0l0 [4, 5-d] pyrimidin-2-one
11/29/2007WO2007134709A1 5-iodotetrazoles for use as antimycotic
11/29/2007WO2007134625A1 New benzothiazinone derivatives and their use as antibacterial agents
11/29/2007WO2007113222A3 Immunogenic composition
11/29/2007WO2007085629A3 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
11/29/2007WO2007084413A3 Methods for treating hepatitis c
11/29/2007WO2007014927A3 Macrocyclic inhibitors of hepatitis c virus
11/29/2007US20070276030 Pyranobenzothiophene derivatives to treat infection with hepatitis c virus
11/29/2007US20070275994 Novel Antinfective Compounds
11/29/2007US20070275992 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers